Get monthly updates on metabolomics news and events
All posts to the category
Combining genome-wide association studies (GWAS) with metabolomics and Mendelian randomization is transforming precision medicine by uncovering causal links between genetic variants and clinical outcomes, rather than just correlations. This approach deepens GWAS insights, helping identify actionable therapeutic targets, yet remains underutilized in research.
Metabolomics highlights the significant role of microbial communities in human health, driving a paradigm shift towards towards personalized, proactive healthcare.
As one of the metabolites responsible for the smell of conifers, alpha-pinene is a fitting choice for our festive Metabolite of the month.
NAFLD is a key player in other chronic diseases – both as a prevalent comorbidity and a contributing factor. Does this mean that treating NAFLD could prevent those conditions?
Why is metabolomics a game-changer in toxicology? We think so, but why are toxicologists split on this question?
